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new nurse assistants, a precertification train-
ing program, and continuing in-service
training, and requires the facility to con-
sider including training regarding the char-
acteristics and method of assessment and
treatment of AIDS. As amended May 2,
this bill would require, in addition, that
each facility consider the unique behav-
ioral and functioning characteristics of in-
dividuals with Huntington's disease, Al-
zheimer's disease, and other dementing
disorders so that the highest quality of care
may be provided. [S. Floor]
* LITIGATION
In Rains v. Belshe, 32 Cal. App. 4th
157 (Feb. 8, 1995), the First District Court
of Appeal upheld the constitutionality of
Health and Safety Code section 1418.8,
which provides for the authorization of nec-
essary but non-emergency medical treat-
ment for nursing home patients who lack the
mental capacity to consent and have no sur-
rogate decisionmaker. Section 1418.8 au-
thorizes a doctor to determine that a patient
is both incompetent and has no surrogate
decisionmaker; once the doctor makes these
two findings, the patient's decisions are made
by an "interdisciplinary team," consisting of
the doctor and a nurse, possibly other staff
members and, where practicable, a patient
representative.
Esther Rains petitioned for a writ of
mandate to invalidate section 1418.8 on
the grounds that it violates the privacy and
due process rights of the nursing home
patients it affects. However, the First Dis-
trict Court of Appeal found that a nursing
home patient's important interest in ob-
taining necessary medical treatment even
when he/she is unable to provide consent
for that treatment outweighs his/her le-
gally protected privacy interest in his/her
own personal bodily autonomy. Further,
the court held that section 1418.8 does not
violate the due process rights of mentally
incompetent patients because the statute
provides a clear test for the determination
of a patient's incapacity to decide on med-
ical care, the opportunity for judicial re-
view of a determination of incapacity, and
the participation of a patient representa-
tive in the decisionmaking process. Critics
of the decision believe the court is im-
properly giving too much deference to
professional medical judgment.
* RECENT MEETINGS
At BNHA's February 16 meeting, then-
Executive Officer Pamela Ramsey reported
that DCA will be adding BNHA to its
Applicant Tracking System (ATS); this
requires BNHA to allocate one staff per-
son to DCA for six months to assist in the
design and implementation of the system.
Ramsey also reported that BNHA is the only
DCA board that is not on DCA's enforce-
ment tracking system; staff is looking into
implementation of this system as well.
At BNHA's May II meeting, Interim
Executive Officer Curt Augustine reported
that some of the Board's planned activities
may be delayed due to the change of ex-
ecutive officers. However, Board staff re-
ported that office automation is under way
with the purchase of two new computers.
BNHA's new Executive Officer Kim Smith
assured the Board and the public that the
expert witness program is her top priority
and she hopes to have the program final-
ized by early fall. [15:1 CRLR 81]
* FUTURE MEETINGS
August 17 in San Francisco.
November 9 in San Diego.
BOARD OF OPTOMETRY
Executive Officer: Karen Ollinger
(916) 323-8720
P ursuant to Business and Professions
Code section 3000 et seq., the Board
of Optometry is responsible for licensing
qualified optometrists and disciplining
malfeasant practitioners. The Board estab-
lishes and enforces regulations pertaining
to the practice of optometry, which are
codified in Division 15, Title 16 of the
California Code of Regulations (CCR).
The Board's goal is to protect the con-
sumer patient who might be subjected to
injury resulting from unsatisfactory eye
care by inept or untrustworthy practition-
ers. The Board consists of nine mem-
bers-six licensed optometrists and three
public members.
U MAJOR PROJECTS
Branch Office Restrictions As Ap-
plied to Independent Practice Associa-
tions. In December 1994, the Board con-
suited Department of Consumer Affairs
(DCA) legal counsel Robert Miller about
two applications for registration of opto-
metric corporations. While the applica-
tions specified only one address, they were
apparently intended to be vehicles for the
establishment of "independent practice
associations" (IPAs) and optometric ser-
vices would actually be rendered through
numerous optometrists practicing at dif-
ferent locations. Because Miller interpre-
ted these offices to be "branch offices"
subject to the restrictions and registration
requirement of Business and Professions
Code section 3077, and because both ap-
plicants expressly disclaimed having any
branch offices, Miller recommended that
the applications be denied. However, the
Board at its December meeting decided to
revisit the section 3077 branch office re-
strictions, and scheduled a discussion of
this issue for its March meeting. [15:1
CRLR 83]
At the Board's March 9-10 meeting,
Miller reported that he had several con-
versations with California Optometric As-
sociation (COA) legal counsel Mark An-
drews regarding this matter. Miller still
contended that by arranging for optomet-
ric services to be provided by professional
practitioners, IPAs are effectively prac-
ticing optometry at multiple locations in
violation of the branch office limitations.
However, Andrews argued that IPAs do
not practice optometry but merely act as
entities which market optometric services,
and thus are not in violation of the branch
office limitations. Miller conceded that
COA's argument may have merit, and in-
formed the Board that there may be alter-
native interpretations of the law in this
regard. The Board generally agreed that
further research should be conducted to
assist it in determining whether IPAs are
in fact practicing optometry. Accordingly,
the Board unanimously agreed to appoint
a committee, including representatives of
the Board and COA, to study issues con-
cerning IPAs and report its findings and
recommendations to the Board at a future
meeting.
Board Publishes Regulatory Propos-
als. On April 7, the Board published notice
of its intent to adopt new sections 1523
and 1524, amend sections 1530, 1531,
1532, 1533, 1535, and 1536, and repeal
section 1526, Title 16 of the CCR, regard-
ing the Board's examination process and
continuing optometric education require-
ments. [15:1 CRLR 82; 14:4 CRLR 89]
Specifically, the Board proposed the fol-
lowing changes:
- New section 1523 would consolidate
the Board's examination and application
requirements into one reference source for
licensure candidates.
- New section 1524 would provide for
the approval of the applications for exam-
ination for those applicants who have paid
the necessary fees and whose credentials
have been approved by the Board's Exec-
utive Officer.
- Amendments to section 1530 would
repeal the existing language and instead
specify that each applicant for licensure
must obtain a passing score of at least 75%
in each of the required examination sec-
tions.
* Amendments to section 1531 would
delete antiquated examination composi-
tion language and clearly delineate each
examination section and its composition.
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- Amendments to section 1532 would
clarify that an applicant who has failed to
pass either the Clinical and Demonstration
or Laws and Regulations examination sec-
tions after a period of five consecutive
calendar years from the date of the first
examination must retake both examina-
tion sections.
- Amendments to section 1533 would
provide that an inspection by an examinee
of the papers he/she wrote while taking the
Board examination must be made by that
person before the expiration of 90 days
after the examination results are mailed.
- Amendments to section 1535 would
specify that the Board requires successful
completion of the National Board of Ex-
aminers in Optometry's (NBEO) Basic
and Clinical Science examination sections
as a condition of eligibility to take the
Board's Clinical Demonstration and Laws
and Regulations examination sections,
and delete language authorizing an appli-
cant to otherwise furnish satisfactory evi-
dence of his/her eligibility pursuant to the
provisions of Chapter 7 of Division 2 of
the Business and Professions Code.
- Amendments to section 1536 would
provide that no more than four hours of
continuing education (CE) coursework shall
be in the area of practice management; CE
offerings approved by the International
Association of Boards of Examiners in
Optometry, known as the Council on Op-
tometric Practitioner Education, are ap-
proved as meeting the required standards
of the Board; a licensee is exempt from CE
requirements if he/she was first licensed
by examination within the twelve months
immediately preceding the annual license
renewal date; and, as a condition of license
renewal, all licensees are required to main-
tain current certification in cardiopulmo-
nary resuscitation (CPR), and the training
required for the CPR certificate may not
be credited toward the required CE hours.
The Board is authorized to require the CPR
certification by AB 2943 (Hauser) (Chap-
ter 578, Statutes of 1994). [14:4 CRLR 89]
The Board also seeks to repeal section
1526, which requires CPR certification as
a condition of license renewal, as that
requirement will now be contained in sec-
tion 1536.
Also on April 7, the Board published
notice of its intent to amend section 1560,
Title 16 of the CCR, to add the drug tetra-
caine hydrochloride, a topical anesthetic
with a maximum usage concentration of
0.5%, to the list of topical pharmaceutical
agents which may be used by California
optometrists in their examination of pa-
tients. [15:1 CRLR 84]
At this writing, the Board is scheduled
to hold a public hearing on all of the above
proposed changes on May 23 in South San
Francisco.
Board Continues to Oppose MBC
Proposal to Permit Medical Assistants
to Perform Optometric Tasks. In Engi-
neers and Scientists of California (ESC),
et al. v. Division of Allied Health Profes-
sions, No. 532588 (Apr. 25, 1994), the
Sacramento County Superior Court in-
validated parts of section 1366, Title 16 of
the CCR, the Medical Board of Califor-
nia's (MBC) regulation which sets forth
the technical supportive services which
may be performed by unlicensed medical
assistants (MAs). Due to procedural irreg-
ularities in the rulemaking process, the
court struck down section 1 366(b)(4), which
permitted MAs to perform "automated
visual field testing, tonometry, or other
simple or automated ophthalmic testing"
under certain conditions. The regulation
was challenged by ESC and COA on both
procedural and substantive grounds, but
the court did not reach ESC/COA's argu-
ment that the regulation impermissibly
allows MAs to perform tasks reserved for
licensed optometrists. [14:4 CRLR 89;
14:2&3 CRLR 94; 14:1 CRLR 72]
In December 1994, MBC's Division of
Licensing (DOL) reinstituted the rulemak-
ing process to reinstate the controversial
provision. This time, the regulatory lan-
guage would permit MAs to "perform oph-
thalmic testing not requiring interpreta-
tion in order to obtain test results, includ-
ing (for example) but not limited to, the
operation of automated objective ophthal-
mic testing equipment, color vision and
depth perception." As published, the lan-
guage precludes MAs from performing
"subjective refractions or any other proce-
dure requiring the exercise of any judge-
ment or interpretation of the data obtained
on the part of the operator." [15:1 CRLR
831
At the Board's March 9-10 meeting,
Executive Officer Karen Ollinger reported
that DOL held a public hearing on the pro-
posed regulatory change on February 3;
following the hearing, DOL took no action
and tabled the issue. Ollinger opined that
after DOL reviews the comments and tes-
timony received, it will approve the change
and submit the proposal to the Office of
Administrative Law (OAL) for review and
approval. Ollinger further reported that no
action was taken to change the Board's
previous decision to oppose the regulatory
change, and provided the Board with a
copy of her February 2 letter to MBC
setting forth the Board's reasons for op-
posing the proposed change; among other
things, Ollinger claimed that MBC lacks
statutory authority to authorize the prac-
tice of optometry by MAs, and that the pro-
posed regulation lacks clarity as required
by the Administrative Procedure Act.
On March 17, DOL released a modified
version of its proposed regulatory change
for public comment. The modified version
retains the changes to section 1366(b)(4)
as published and described above; amends
section 1366(a)(1) to declare that MAs may
not administer local anesthetic agents; and
repeals section 1366(d) (which prohibits
MAs from practicing optometry) as dupli-
cative of existing law. After another public
hearing at its May 11 meeting, DOL adopt-
ed the revised language; at this writing,
DOL staff is preparing the rulemaking file
on these proposed regulatory changes for
submission to OAL. (See agency report on
MBC for related discussion.)
U LEGISLATION
SB 510 (Maddy). Under existing law,
the practice of optometry includes, among
other things, the examination of the human
eye or eyes, or its or their appendages; the
analysis of the human vision system, ei-
ther subjectively or objectively; and the
use of pharmaceutical agents for the sole
purpose of the examination of the human
eye or eyes for any disease or pathological
condition. Existing law authorizes the Board
of Optometry, with the advice and consent
of the Medical Board of California, to des-
ignate the specific topical pharmaceutical
agents to be used for these purposes. As
amended May 2, this bill would state the
intent of the legislature that the scope of
optometric practice be as set forth in this
bill, and that optometrists be prohibited
from performing acts outside the scope of
practice as set forth in the bill.
In a modified reintroduction of 1994's
AB 2020 (Isenberg) [14:2&3 CRLR 94],
SB 510 would provide that the practice of
optometry includes, among other things,
the examination of the human eye, or its
appendages, and the analysis and diagno-
sis of conditions of the human vision sys-
tem, either subjectively or objectively.
The bill would delete the requirement that
the Board designate the pharmaceutical
agents to be used, and authorize the use of
specified diagnostic pharmaceutical agents
for purposes of examining the human eye
or eyes or its or their appendages for any
disease or pathological condition. The bill
would also authorize the use, prescribing,
and dispensing of specified therapeutic
pharmaceutical agents (TPAs) to a patient
by an optometrist for the purposes of treat-
ing the human eye or eyes, or its or their
appendages, for any disease or pathologi-
cal condition by an optometrist who meets
specified requirements. It would exclude
from these TPAs controlled substances pec-
ified in state and federal law, and prohibit
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the administration by an optometrist of
drugs administered by injection or intra-
venously. This bill would specify addi-
tional practices that are included and ex-
cluded from the practice of optometry.
SB 510 would also provide that any
use, prescribing, or dispensing of a phar-
maceutical agent to a patient by an optom-
etrist pursuant to these provisions is lim-
ited to that which is incidental to the prac-
tice of optometry, and would specify that
dispensing by the optometrist to a patient
be without charge. This bill would make
it a misdemeanor for any person licensed
as an optometrist to refer a patient to a
pharmacy that is owned by that licensee or
in which the licensee has proprietary in-
terest.
Existing law authorizes only a physician,
dentist, podiatrist, or veterinarian to pre-
scribe or write a prescription and to dispense
drugs and devices to patients in his/her of-
fice, under prescribed conditions. Existing
law authorizes the Board to determine edu-
cational and examination requirements, with
the advice and consent of MBC, of optome-
trists to be permitted to use diagnostic phar-
maceutical agents. SB 510 would instead
authorize the Board to determine educational
and examination requirements, with the ad-
vice and consent of MBC, of optometrists
who are issued an original certificate of reg-
istration before January 1, 1996, to be per-
mitted to use diagnostic pharmaceutical
agents. This bill would establish a seven-
member pharmaceutical advisory commit-
tee with a prescribed membership to provide
advice to the Board as to the use of diagnos-
tic and therapeutic agents.
This bill would also authorize the Board
to determine educational and examination
requirements, with the advice and consent
of the pharmaceutical advisory committee
established by the bill, for licensure of
optometrists who are issued an original
certificate of registration on or after Janu-
ary 1, 1996, to be permitted to use diag-
nostic pharmaceutical agents and use, dis-
pense, or prescribe TPAs. It would autho-
rize only optometrists who successfully
complete several examination and train-
ing requirements to be permitted to use,
dispense, or prescribe TPAs.
Existing law requires the Board to re-
quire, by regulation, that optometrists, as
a condition of licensure renewal, submit
proof of having obtained certain continu-
ing education. This bill would require li-
censees to complete, at a minimum, 25
hours of continuing education per year,
and would require that one-third of those
hours relate to the diagnosis, treatment,
and management of ocular disease.
This bill would state the intent of the
legislature that to theextent an optometrist's
scope of practice is equivalent to that of a
physician, and optometrist shall be subject
to the same criminal penalties as could be
applied to a physician. [S. B&P]
AB 1969 (Isenberg), as amended April
5, is very similar to SB 510 but would
include within the expanded scope of
practice of optometrists the examination
of the adnexa for any disease or patholog-
ical condition; and would authorize the
use, prescribing, and dispensing of spec-
ified TPAs to a patient by an optometrist
for the purposes of treating the human eye
or eyes, or its or their appendages and
adnexa. Also, instead of providing that
any use, prescribing, or dispensing of a
pharmaceutical agent to a patient by an
optometrist is limited to that which is
incidental to the practice of optometry,
AB 1969 would require that such use,
prescribing, or dispensing of a pharma-
ceutical agent be limited only to the prac-
tice of optometry. [A. Health]
SB 668 (Polanco). Existing law pro-
vides that it is unlawful for a person to
engage in the practice of optometry with-
out first obtaining a certificate of registra-
tion from the Board. As amended April 6,
this bill-which is a reintroduction of
1993's AB 1894 (Polanco)-would autho-
rize ancillary personnel who work under
the supervision of an optometrist to assist
in the preparation of the patient and the
preliminary collection of data. It would
prohibit an optometrist from permitting
ancillary personnel to collect data requir-
ing the exercise of professional judgment
or skill of an optometrist that includes
performing any subjective refraction pro-
cedures, contact tonometry, data analysis,
or diagnosis, or prescribing and determin-
ing any treatment plan. [A. Health]
SB 640 (Craven). Existing law pro-
vides for the examination and licensure of
spectacle lens and contact lens dispensers,
and prohibits a person from fitting or ad-
justing contact lenses without being regis-
tered or working under the direct respon-
sibility and supervision of a registered
contact lens dispenser who is present on
the registered premises. As amended May
2, this bill would prohibit, commencing
January 1, 1997, any person located out-
side of California from shipping, mailing,
or delivering contact lenses to residents of
California unless registered with MBC's
Division of Licensing. The bill would re-
quire the nonresident contact lens seller to
complete an application, pay prescribed
licensure and renewal fees, and satisfy
various conditions in order to obtain and
maintain registration. The bill would pro-
vide that contact lenses may be dispensed
only within one year of the date on the
written prescription, and if the written pre-
scription is unavailable to the seller, it
would require the seller to directly com-
municate with the prescriber to confirm
the prescription. The bill would also set
forth circumstances under which registra-
tion may be denied, suspended, or re-
voked, and establish procedures for re-
newal of registration. It would authorize
the Division of Licensing to adopt regula-
tions necessary to administer these provis-
ioas. [A. Health]
AB 1107 (Campbell), as amended May
15, would, notwithstanding existing law,
permit pharmacists, including nonresident
pharmacies, to dispense replacement con-
tact lenses, as defined in accordance with
certain requirements. This bill would also
add a requirement that nonresident phar-
macies maintain records of all replacement
contact lenses shipped, mailed, or deliv-
ered to California residents. [A. Appr]
U LITIGATION
In United States v. Vision Service Plan,
No. 94CV02693, filed by the U.S. Depart-
ment of Justice (DOJ) in U.S. District
Court for the District of Columbia in De-
cember 1994, the federal government al-
leged that California-based Vision Service
Plan (VSP), the country's largest vision
care insurance plan, violated section 1 of
the Sherman Act by illegally requiring
so-called "most favored nation" (MFN)
clauses in its contracts with optometrists.
According to DOJ, the MFN clause pro-
hibits each VSP optometrist from charg-
ing VSP patients higher fees than those
charged non-VSP patients; requires VSP
optometrists to notify VSP if a published
VSP fee schedule exceeds their usual and
customary fee, and requires them to accept
the lower fee; and requires participating
optometrists to accept reduced fees if VSP
determines the optometrist has charged it
higher fees than those charged non-VSP
patients. According to Anne Bingaman,
assistant attorney general in charge of
DOJ's Antitrust Division, the MFN clause
discourages optometrists from offering
discounts to non-VSP patients from com-
peting plans, and vision care insurance
plans that had previously contracted with
optometrists at discounts between 20-
40% were no longer able to obtain those
discounts.
On the same day it filed the lawsuit,
however, DOJ also filed a proposed con-
sent decree which-if approved by the
court-would settle the matter. Under the
proposed consent decree, VSP will dis-
continue its practice of using the chal-
lenged MFN clause and will adopt a new
fee system based on a range of fees ac-
cepted by optometrists. Also pursuant to
the proposed consent decree, VSP would
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be prohibited from maintaining, adopt-
ing, or enforcing any policy or practice of
linking payments made by VSP to any
VSP panel optometrist to fees charged by
the optometrist to any non-VSP patient or
any non-VSP plan; differentiating its pay-
ments to, or other treatment of, any VSP
panel optometrist because the optometrist
charges any fee lower than that charged by
the optometrist to the VSP, to any non-
VSP patient, or to any non-VSP plan; tak-
ing any action to discourage any VSP panel
optometrist from participating in any non-
VSP plan or from offering or charging any
fee lower than that paid to the optometrist
by VSP to any non-VSP patient or to any
non-VSP plan; monitoring or auditing the
fees that any VSP panel optometrist charges
any non-VSP patient or non-VSP plan;
and communicating in any fashion with
any VSP panel optometrist regarding the
his/her participation in any non-VSP plan
or regarding the his/her fees charged to
any non-VSP patient or to any non-VSP
plan. [15:1 CRLR 83-84] At this writing,
the court has not yet approved the pro-
posed consent decree.
In State of Florida v. Johnson & John-
son, et al., No. 94-619-CIV-J-20, the Flor-
ida Attorney General filed a nationwide
class action in U.S. District Court for the
Middle District of Florida against Bausch
& Lomb Inc., Johnson & Johnson Vision
Products Inc., the American Optometric
Association, the Contact Lens and Ante-
rior Segment Society, and nine optome-
trists; the Attorney General contends that
the defendants engaged in a conspiracy
to restrict the sale of soft contact lenses.
According to the action, the defendants
made soft contact lenses available only to
optometrists, ophthalmologists, and opti-
cians-who often mark up the lens prices
significantly-and not to alternative chan-
nels of distribution such as pharmacies,
mail-order firms, and similar entities which
may offer discounted prices on the lenses.
The action further claims that the named
optometrists and the Society tried to per-
suade lens manufacturers not to distribute
soft lenses to alternative chains of distri-
bution, and that the Society threatened not
to prescribe the lenses of any manufac-
turer which sold its product to pharmacies
or mail-order channels of distribution. At
this writing, the matter is not expected to
be heard until at least late 1996 or early
1997.
* RECENT MEETINGS
At its March 9-10 meeting, the Board
decided to pursue legislation authorizing
it to conveit its annual license renewal
system to a biennial license renewal sys-
tem.
Also at its March meeting, the Board
received testimony in support of and op-
position to a proposal to allow optometrists
to use collagen punctal plugs as a diagnostic
tool. Those in support of the proposal testi-
fied that it is a quick and progressive pro-
cedure; those opposed contended that it is
invasive surgery which exceeds an optom-
etrist's scope of practice. Following discus-
sion, the Board agreed to accept collagen
punctal plugs as a diagnostic tool for optom-
etrists which falls within the scope of prac-
tice of optometry. This policy appears to
conflict with the Board's earlier position on
this issue; in May 1991, the Board deter-
mined that "the use of collagen implants by
an optometrist would not be within the cur-
rent scope of optometric practice." [11:3
CRLR 99-100]
* FUTURE MEETINGS
May 22-23 in San Francisco.
August 24-25 in Sacramento.
December 1-2 in Orange County.
BOARD OF PHARMACY
Executive Officer: Patricia Harris
(916) 445-5014
p ursuant to Business and Professions
Code section 4000 et seq., the Board
of Pharmacy grants licenses and permits
to pharmacists, pharmacies, drug manu-
facturers, wholesalers, medical device re-
tailers, and sellers of hypodermic needles.
It regulates all sales of dangerous drugs,
controlled substances, and poisons. The
Board is authorized to adopt regulations,
which are codified in Division 17, Title 16
of the California Code of Regulations
(CCR). To enforce its regulations, the
Board employs full-time inspectors who
investigate complaints received by the
Board. Investigations may be conducted
openly or covertly as the situation de-
mands.
The Board conducts fact-finding and
disciplinary hearings and is authorized by
law to suspend or revoke licenses or per-
mits for a variety of reasons, including
professional misconduct and any acts ub-
stantially related to the practice of phar-
macy.
The Board consists of ten members,
three of whom are nonlicensees. The re-
maining members are pharmacists, five of
whom must be active practitioners. All are
appointed for four-year terms.
On January 30, Governor Wilson ap-
pointed Caleb Zia to the Board as a public
member. Zia is the President and Execu-
tive Director of the Minority Business
Council of Orange County, as well as the
President of Chesterfield Corporation, a
business consulting and management firm;
he also serves on the board of Allied Bio-
technology International, Inc., a research
and manufacturing company which pro-
duces bio-pharmaceuticals, diagnostic as-
says, and health cire products.
U MAJOR PROJECTS
Medical Device Retailer Locked Stor-
age. AB 1807 (Bronshvag) (Chapter 26,
Statutes of 1994) authorizes a medical de-
vice retailer to establish a locked storage
facility for furnishing dangerous devices
in emergencies or after working hours;
provides that the locked storage may be
installed or placed in a service vehicle of
the medical device retailer for after-hours
or emergency delivery to patients who
have prescriptions for dangerous devices;
and authorizes the Board to adopt regula-
tions to permit an exempt person to direct
a non-licensed employee of a medical de-
vice retailer who operates a service vehi-
cle equipped with locked storage to de-
liver a dangerous device from the locked
storage to patients having prescriptions
for dangerous devices. [14:1 CRLR 74]
However, under existing section 1748.1,
Title 16 of the CCR, only an exemptee
(either a California registered pharmacist
or someone who becomes licensed by the
Board as an "exemptee" after passing a
Board-administered exam) may furnish
dangerous devices from a locked storage
of a medical device retailer.
On March 17, the Board published no-
tice of its intent to amend section 1748.1
to implement AB 1807 and expand the per-
sonnel authorized to provide emergency
or after-hours delivery of dangerous de-
vices to patients of a medical device re-
tailer to include an employee who oper-
ates a service vehicle. The proposed amend-
ments would require that dangerous de-
vices be furnished from the locked storage
only by an exemptee or upon the oral or
written direction of an exemptee to an em-
ployee of the medical device retailer who
operates the service vehicle. The amend-
ments further provide that the exemptee is
responsible for checking the contents of
the locked storage and for noting on the
inventory the dangerous devices furnished
within 72 hours of the furnishing of the
dangerous device from the locked storage
to a patient.
At this writing, the Board is scheduled
to hold a public hearing on the proposed
amendments to section 1748.1 on May 24
in Sacramento.
Examination Admission Require-
ments. Also on March 17, the Board pub-
lished notice of its intent to amend section
1719, Title 16 of the CCR, which specifies
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